Monograph

N01BX04 - Capsaicin

Propably not porphyrinogenic

Rationale

Substrate for several human CYPs. Even if some systemic absorption may take place the concentration of the substance in the creme is quite low and systemic exposure probably low.

Chemical description

Local analgesic; creme 0.075%. Selective analgesic effect in local application, probably through its effect on substance P in the afferent C-fibres. No data on metabolism.

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes N01B / N01BX or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Qutenza · Qutenza 179 mg, Huidpleister

Belgium

Qutenza · Qutenza 179 mg patch cut. sachet

United Kingdom

Axsain · Axsain 0.075% cream · Capsaicin · Capsaicin 0.006% cream · Capsaicin 0.025% cream · Capsaicin 0.075% cream · Qutenza · Qutenza 179mg cutaneous patches · Zacin · Zacin 0.025% cream

Denmark